Breakthrough in Broad-Spectrum Malaria Therapy Hunt | Mirage News
Scientists at La Trobe University discovered WD34, an antibody-like molecule that binds to AMA1, inhibiting malaria parasite infection. WD34 targets a conserved region in AMA1, making it effective against multiple malaria species, offering hope for a broad-spectrum vaccine. Pre-clinical trials show promising results.
Reference News
Scientists at La Trobe University discovered WD34, an antibody-like molecule that binds to AMA1, inhibiting malaria parasite infection. WD34 targets a conserved region in AMA1, making it effective against multiple malaria species, offering hope for a broad-spectrum vaccine. Pre-clinical trials show promising results.
Scientists at La Trobe University discovered WD34, an antibody-like molecule that binds to AMA1, inhibiting malaria parasite infection stages and showing potential for broad-spectrum malaria therapy.